A New York City based broker-dealer active in equity private placements with emerging growth companies has been accused of fraud on grand scale by its regulator FINRA. John Carris Investments, founded by George Carris in 2009, is facing multiple allegations centering on stock manipulation, fraudulent self-offerings of securities, use of firm funds to pay personal expenses, falsifying tax documents and not paying staff payroll taxes withdrawn from employee’s paychecks. The regulator wants George Carris, along with other principals of the firm, Andrey Tkatchenko and Jason Barter sanctioned for securities fraud. In the FINRA complaint the regulator alleges Carris manipulated the price of shares of then-OTC Pink-quoted FibroCell Sciences (FCSC):
“This scheme was motivated by the Manipulation Respondents' interest in increasing the volume and price of sales of Fibrocell shares, including in ongoing Private Placements of Public Equity ("PIPEs") for which John Carris Investments acted as a placement agent. From these placements, the Manipulation Respondents earned commissions ranging from 7-10% and Fibrocell warrants- from which respondents could profit by cashless exercise. By engaging in prearranged trading during the Manipulation Period, between May 1, 2010 and September 30, 2010, the Respondents created volume and also gave the appearance of greater liquidity, manipulated the price by which the shares were bought and sold, and prevented large sales of blocks of shares from being sold into the market (which would depress the stock price).